Floxuridine (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Floxuridine drug offered from Fresenius Kabi USA, LLC. This Antimetabolite [EPC],Deoxyuridine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: FLOXURIDINE
SUBSTANCE NAME: FLOXURIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimetabolite [EPC],Deoxyuridine [Chemical/Ingredient]
ROUTE: INTRA-ARTERIAL
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2001-03-15
END MARKETING DATE: 0000-00-00


Floxuridine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFloxuridine from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/5mL)
START MARKETING DATE: 2001-03-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-145_c27f9bb1-7621-4989-8dba-c8b9fa5503a8
PRODUCT NDC: 63323-145
APPLICATION NUMBER: ANDA075837

Other FLOXURIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCFloxuridine